Webinar - Managing Principal Pierre Cremieux Participates in Panel Discussion on Antitrust Challenges to Patent Settlements

Event:Antitrust Challenges to Patent Settlements after FTC v. Actavis
Date:June 25, 2013
Host:Ballard Spahr
Times:9:00–10:00 a.m. (PST) / 12:00–1:00 p.m. (EST)

Dr. Cremieux participates in a panel discussion on the U.S. Supreme Court's impending decision in Federal Trade Commission v. Actavis. The ruling is expected to establish a standard for assessing antitrust liability for so-called reverse payment patent settlements between brand name and generic drug manufacturers. Dr. Cremieux is part of a group of antitrust experts who filed an amicus curiae brief in this matter.

Associated Experts & Staff